Stephen Christiansen
Family Medicine · Springfield, MONPI 1558367003
Payments from drug & device makers
Across 201 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$612
- Novo Nordisk$535
- AstraZeneca$337
- Teva Pharmaceuticals USA, Inc.$332
- Lilly USA, LLC$295
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$210
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,36396%
- Education$1344%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $612 |
| Novo Nordisk | 34 | $535 |
| AstraZeneca(2 entities) | 19 | $337 |
| Teva Pharmaceuticals USA, Inc. | 20 | $332 |
| Lilly USA, LLC | 19 | $295 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $210 |
| E.r. Squibb & Sons, L.L.C. | 6 | $119 |
| Novartis | 7 | $106 |
| Dexcom, Inc. | 4 | $97 |
| Astellas Pharma US Inc | 5 | $92 |
| Pfizer | 5 | $85 |
| Boehringer Ingelheim | 4 | $67 |
| Merck | 3 | $67 |
| Johnson & Johnson | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Amgen | 4 | $60 |
| Eisai Inc. | 3 | $45 |
| Exact Sciences | 3 | $44 |
| Endogastric Solutions, Inc | 1 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Tonix Medicines, Inc. | 1 | $23 |
| Bayer | 1 | $22 |
| Boston Scientific | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Indivior Inc. | 1 | $14 |
| Electromed, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Medtronic | 1 | $12 |
How this compares
$3,497 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 93 | $104,855 |
| Taltz SyringeIxekizumab | 13 | $93,071 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 59 | $37,610 |
| EliquisApixaban | 43 | $34,182 |
| LinzessLinaclotide | 29 | $28,190 |
| JardianceEmpagliflozin | 36 | $26,329 |
| OxycontinOxycodone Hcl | 16 | $19,596 |
| VraylarCariprazine Hcl | 13 | $18,513 |
| MounjaroTirzepatide | 17 | $17,562 |
| CreonLipase/Protease/Amylase | 11 | $17,549 |
| MyrbetriqMirabegron | 24 | $16,355 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $14,347 |
| TrulicityDulaglutide | 14 | $13,769 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 340 | $10,734 |
| MultaqDronedarone Hcl | 12 | $9,633 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $535 | $104,85593 claims |
| AbbVieLinzess, Vraylar, Creon | $612 | $64,25253 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $337 | $46,48897 claims |
| PfizerEliquis | $85 | $34,18243 claims |
| Lilly USA, LLCMounjaro, Trulicity | $295 | $31,33131 claims |
| Boehringer IngelheimJardiance | $67 | $26,32936 claims |
| Astellas Pharma US IncMyrbetriq | $92 | $16,35524 claims |
| MerckBelsomra | $67 | $6,63716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Springfield
- William HowittSpringfield$19.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Stephen AdamsSpringfield$636K
- Cory BethmannSpringfield$621K
- Roger CadySpringfield$175K
- Don BrockmanSpringfield$31K
- James van RiessenSpringfield$25K
- Timothy JenningsMaryland Heights$30.2M
- Rupal TrivediSaint Louis$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.